Free Trial

Microbot Medical (MBOT) Stock Price, News & Analysis

Microbot Medical logo
$3.85 +0.29 (+8.15%)
Closing price 04:00 PM Eastern
Extended Trading
$3.96 +0.11 (+2.73%)
As of 07:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Microbot Medical Stock (NASDAQ:MBOT)

Key Stats

Today's Range
$3.52
$3.94
50-Day Range
$2.36
$3.85
52-Week Range
$0.82
$3.94
Volume
5.48 million shs
Average Volume
3.08 million shs
Market Capitalization
$175.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.00
Consensus Rating
Buy

Company Overview

Microbot Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
38th Percentile Overall Score

MBOT MarketRank™: 

Microbot Medical scored higher than 38% of companies evaluated by MarketBeat, and ranked 719th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Microbot Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Microbot Medical has received no research coverage in the past 90 days.

  • Read more about Microbot Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Microbot Medical are expected to grow in the coming year, from ($0.71) to ($0.52) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Microbot Medical is -6.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Microbot Medical is -6.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Microbot Medical has a P/B Ratio of 5.75. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    23.49% of the float of Microbot Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Microbot Medical has a short interest ratio ("days to cover") of 4.6.
  • Change versus previous month

    Short interest in Microbot Medical has recently increased by 2.26%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Microbot Medical does not currently pay a dividend.

  • Dividend Growth

    Microbot Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    23.49% of the float of Microbot Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Microbot Medical has a short interest ratio ("days to cover") of 4.6.
  • Change versus previous month

    Short interest in Microbot Medical has recently increased by 2.26%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Microbot Medical has a news sentiment score of 0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 14 news articles for Microbot Medical this week, compared to 2 articles on an average week.
  • Search Interest

    40 people have searched for MBOT on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    6 people have added Microbot Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Microbot Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.74% of the stock of Microbot Medical is held by insiders.

  • Percentage Held by Institutions

    Only 16.30% of the stock of Microbot Medical is held by institutions.

  • Read more about Microbot Medical's insider trading history.
Receive MBOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Microbot Medical and its competitors with MarketBeat's FREE daily newsletter.

MBOT Stock News Headlines

Could This Be the End of Retirement Worries?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.tc pixel
See More Headlines

MBOT Stock Analysis - Frequently Asked Questions

Microbot Medical's stock was trading at $1.12 at the beginning of 2025. Since then, MBOT stock has increased by 243.8% and is now trading at $3.85.

Microbot Medical Inc. (NASDAQ:MBOT) released its earnings results on Tuesday, August, 12th. The biotechnology company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.08) by $0.02.

Microbot Medical shares reverse split before market open on Monday, May 9th 2016.The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 6th 2016. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Microbot Medical's top institutional investors include Geode Capital Management LLC (1.09%), DNB Asset Management AS (0.53%), Lazari Capital Management Inc. (0.06%) and XTX Topco Ltd (0.05%).
View institutional ownership trends
.

Shares of MBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Microbot Medical investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), TransEnterix (TRXDW), Pfizer (PFE), Plug Power (PLUG) and Novavax (NVAX).

Company Calendar

Last Earnings
8/12/2025
Today
8/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:MBOT
CIK
883975
Employees
20
Year Founded
2010

Price Target and Rating

High Price Target
$9.00
Low Price Target
$9.00
Potential Upside/Downside
+135.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.58)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$11.44 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-76.27%
Return on Assets
-67.54%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
12.06
Quick Ratio
12.06

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.67 per share
Price / Book
5.69

Miscellaneous

Outstanding Shares
45,550,000
Free Float
43,387,000
Market Cap
$173.77 million
Optionable
Optionable
Beta
1.15

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:MBOT) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners